Skip to main content
    S

    SINTX Technologies Inc (SINT)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $2.07
    -0.06 (-2.82%)

    Market Cap: $13.76M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    46%(17/37)
    Avg Surprise
    -43.42%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.31
    Range$-0.33 - $-0.28
    3 analysts
    EPS Revisions
    2
    0
    7d
    2
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.45+31.1%
    60d ago$-0.45+31.1%
    30d ago$-0.34+11.1%
    7d ago$-0.34+11.1%
    Current$-0.31
    Revenue Consensus
    $1M
    Range$800000 - $2M
    3 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.13
    Range$-0.24 - $0.03
    3 analysts
    Revenue Consensus
    $1M
    Range$406670 - $2M
    3 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.13---
    Sep 26EST
    		-$-0.31---
    Jun 26
    Reported Aug 11
    		$-0.75$-0.69-8.70%Miss+28.6%
    Mar 26
    Reported May 15
    		$-0.70$-0.66-6.06%Miss+45.7%
    Dec 25
    Reported Mar 18
    		$N/A$-0.55N/ABeat-
    Sep 25
    Reported Nov 12
    		$-3.46$-0.55-529.09%Miss-73.9%
    Jun 25
    Reported Aug 14
    		$-1.05$-0.79-32.91%Miss+69.9%
    Mar 25
    Reported May 15
    		$-1.29$-0.71-81.69%Miss+87.1%
    Dec 24
    Reported Mar 19
    		$-4.37$-1.82-140.11%Miss-1020.5%
    Sep 24
    Reported Nov 12
    		$-1.99N/A+62.38%Beat+98.5%
    Jun 24
    Reported Aug 13
    		$-3.49$-5.31+34.27%Beat+97.9%
    Mar 24
    Reported May 13
    		$-10.00$-18.00+44.44%Beat+96.8%
    Dec 23
    Reported Mar 27
    		$-0.39$-0.75+48.00%Beat+98.9%
    Sep 23
    Reported Nov 14
    		$-133.04$-152.00+12.47%Beat+94.0%
    Jun 23
    Reported Aug 8
    		$-167.90$-140.00-19.93%Miss+90.7%
    Mar 23
    Reported May 15
    		$-309.82$-222.00-39.56%Miss+86.7%
    Dec 22
    Reported Mar 29
    		$-34.69$-5.51-529.58%Miss-395.6%
    Sep 22
    Reported Nov 14
    		$-2200.00$-2200.00+0.00%Beat+3.8%
    Jun 22
    Reported Aug 12
    		$-1814.00$-2400.00+24.42%Beat+3.3%
    Mar 22
    Reported May 13
    		$-2335.60$-2300.00-1.55%Miss-19363.3%
    Dec 21
    Reported Mar 25
    		$-7.00$-11.50+39.13%Beat+99.9%
    Sep 21
    Reported Nov 12
    		$-2286.00$-2400.00+4.75%Beat-16.6%
    Jun 21
    Reported Aug 12
    		$-1875.40$-2200.00+14.75%Beat+46.0%
    Mar 21
    Reported May 13
    		$-12.00$-9.00-33.33%Miss+99.8%
    Dec 20
    Reported Mar 22
    		$-11600.00$-1800.00-544.44%Miss-28192.7%
    Sep 20
    Reported Nov 16
    		$-1960.00$-1600.00-22.50%Miss+89.2%
    Jun 20
    Reported Aug 12
    		$-3476.00$-2800.00-24.14%Miss+94.7%
    Mar 20
    Reported May 13
    		$-5816.40$-3600.00-61.57%Miss-19388100.0%
    Dec 19
    Reported Mar 25
    		$-41.00$-57.50+28.70%Beat-116.9%
    Sep 19
    Reported Nov 18
    		$-18200.00$-15400.00-18.18%Miss-2166566.7%
    Jun 19
    Reported Aug 15
    		$-66200.00N/A+78.78%Beat-4012021.2%
    Mar 19
    Reported May 16
    		$0.03N/A+104.29%Beat+100.0%
    Dec 18
    Reported Mar 11
    		$-18.90$-23.10+18.18%Beat+99.1%
    Sep 18
    Reported Nov 14
    		$-0.84$-0.73-15.07%Miss+100.0%
    Jun 18
    Reported Aug 14
    		$-1.65$-0.74-122.97%Miss+90.8%
    Mar 18
    Reported May 15
    		$-462060.46$-462000.46-0.01%Miss-256700155.6%
    Dec 17
    Reported Mar 29
    		$-2130.00$-1995.00-6.77%Miss-
    Sep 17
    Reported Oct 31
    		$-432002.16$-360001.80-20.00%Beat-
    Jun 17
    Reported Sep 22
    		$-18.00$-28.80+37.50%Beat-
    Mar 17
    Reported May 18
    		$-0.18N/A+99.47%Beat-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCF-0.97xFCF Yield-102.97%
    Profitability
    Profit Margin0.00%Operating Margin-638.00%
    ROE-255.90%ROIC-182.03%
    Financial Health
    Debt/Equity0.02xInterest Coverage-291.38x
    Current Ratio2.36xQuick Ratio1.60x
    Trading Statistics
    Beta0.59Avg Volume83.67K
    52-Week High$4.4652-Week Low$1.40

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$2.15
    SMA 20$1.99
    SMA 50$1.78
    SMA 200$2.36
    EMA 10$2.09
    EMA 20$2.01
    EMA 50$1.88
    EMA 200$2.24

    MACD

    Line: 0.11Signal: 0.12Hist: -0.00

    ADX

    ADX: 38.4+DI: 26.1-DI: 9.7

    Aroon & PSAR

    Aroon Up68.0
    Aroon Down28.0
    PSAR$2.39

    Bollinger Bands

    Upper Band$2.37
    Lower Band$1.60
    %B Position3850%(Upper)
    Band Width0.61

    RSI (14-Day)

    Neutral
    58.3

    Momentum Oscillators

    Stoch %K55.6
    Stoch %D59.0
    Williams %R-49.6
    ROC (10d)2.0%
    Momentum0.04
    CCI (20d)46.9
    MFI (14d)40.2

    Volatility Measures

    ATR (14d)$0.14(7.0%)
    StdDev (20d)0.19
    Hist Vol55.1%(High)

    Volume Flow

    VWAP$2.11
    OBV26.9M
    AD Line-22.3M
    CMF (20d)-0.161

    Volume Metrics

    Avg Vol (20d)91.0K
    Vol Ratio0.4x(Low)
    VWMA (20d)$2.08

    Pivot Points

    R3$2.21
    R2$2.18
    R1$2.15
    Pivot Point$2.12
    S1$2.09
    S2$2.06
    S3$2.03

    Advanced Oscillators

    TSI29.39
    Ultimate Osc43.9
    KST271.31

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$452,000$380,000$290,000$208,000$151,000$369,000$542,000$799,000$859,000$687,000$902,000$678,000
    Cost of Revenue$174,000$236,000$102,000$115,000$94,000$246,000$154,000$210,000$224,000$223,000$445,000$117,000
    Gross Profit$278,000$144,000$188,000$93,000$57,000$123,000$388,000$589,000$635,000$464,000$457,000$561,000
    Operating Expenses$3.17M$3.35M$2.51M$3.45M$2.72M$2.51M$2.12M$7.00M$3.35M$3.66M$3.18M$4.17M
    R&D$573,000$364,000$969,000$1.26M$1.24M$1.12M$709,000$796,000$1.68M$2.02M$1.84M$2.52M
    SG&A$2.32M$2.54M$1.63M$2.10M$1.42M$1.32M$1.00M$802,000$1.07M$1.12M$895,000$990,000
    Operating Income$-2,888,000$-3,207,000$-2,318,000$-3,355,000$-2,665,000$-2,383,000$-1,732,000$-6,408,000$-2,710,000$-3,197,000$-2,723,000$-3,614,000
    Interest Income$12,000$22,000$45,000$43,000$46,000$41,000$41,000$24,000$23,000$19,000$17,000$33,000
    Interest Expense$2,000$12,000$12,000$13,000$14,000$13,000$14,000$9,000$4,000$2,000$0$0
    Income Before Tax$-2,706,000$-2,821,000$-2,215,000$-3,539,000$-2,318,000$-2,292,000$-1,695,000$-6,239,000$-2,204,000$-886,000$-2,321,000$-3,190,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-2,706,000$-2,821,000$-2,215,000$-3,539,000$-2,318,000$-2,292,000$-1,695,000$-6,239,000$-2,204,000$-886,000$-2,321,000$-3,190,000
    EBITDA$-2,562,000$-2,675,000$-2,088,000$-3,410,000$-2,197,000$-2,130,000$-1,497,000$-5,922,000$-1,816,000$-483,000$-1,890,000$-2,760,000
    EBIT$-2,716,000$-2,831,000$-2,248,000$-3,569,000$-2,350,000$-2,320,000$-1,722,000$-6,254,000$-2,223,000$-903,000$-2,338,000$-3,223,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about SINT

    Government Contracts

    Gov Obligations (TTM)
    $15000
    Gov Obligations / Revenue
    N/A
    Obligations YoY
    N/A
    Active Awards
    2
    New Awards (TTM)
    1
    Avg Remaining Term
    N/A

    Top agency: Department of Defense at 100.0% of trailing twelve month obligations across 1 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    N0017325P5624Department of DefenseDepartment of the Navy$15000Aug 22, 2025

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Transcript: SINTX Technologies Q2 2026 Earnings Conference Call

    SINTX Technologies reported a significant 199% year-over-year revenue increase in Q2 2026, reaching $452,000, driven by OEM industrial manufacturing and early commercial sales of its foot and ankle wedge system. Despite...

    Benzinga•10/14/26•Neutral

    Sintx Technologies Completes Class B Warrant Exercises

    Sintx Technologies (SINT) has completed the exercises of its Class B Common Stock Purchase Warrants, generating approximately $2.0 million in gross proceeds from funded exercises and related exchanges. The company issued...

    The Globe and Mail•10/10/26•Neutral

    SINTX Technologies nets $2.01M from Class B warrant call, issues 651,204 shares

    SINTX Technologies announced it received over $2 million from exercised Class B warrants, leading to the issuance of 651,204 shares of common stock. The Class B warrant call period expired on October 8, 2026...

    TradingView•10/9/26•Somewhat-Bullish

    Maxim Group Maintains Sintx Technologies(SINT.US) With Buy Rating, Maintains Target Price $6

    Maxim Group has reiterated its Buy rating for Sintx Technologies (SINT.US), maintaining a target price of $6. This indicates the firm's continued confidence in the company's stock performance.

    Moomoo•10/4/26•Bullish

    Sintx Technologies, Inc. (SINT) Stock Price, News, Quote & History

    Sintx Technologies, Inc. (SINT) stock closed at $2.21, up 3.76% at the close of October 2, 2026, with an overnight price of $2.11 due to after-hours trading. The company, an advanced ceramics firm...

    Yahoo! Finance Canada•10/2/26•Neutral

    SINT Valuation and Fair Value

    P/FCF
    -1.0x
    P/B
    2.1x
    See GNG's fair value

    SINT Profitability: Margins, ROIC and FCF

    Gross margin
    52.9%
    Operating margin
    -638.0%
    Net margin
    0.0%
    ROIC
    -182.0%
    ROE
    -255.9%
    FCF margin
    -777.1%
    FCF yield
    -103.0%

    SINT Competitors

    CompanyTicker
    Estrella Immunopharma Inc.ESLA
    Citius Pharmaceuticals IncCTXR
    Pasithea Therapeutics CorpKTTA
    Vyome Holdings, Inc.HIND
    Dare Bioscience IncDARE
    Tvardi Therapeutics, Inc.TVRD
    IRIDEX CorporationIRIX
    Biofrontera IncBFRI

    Sector: Healthcare

    SINT Analyst Ratings

    Consensus
    Buy
    Analysts
    4
    Strong Buy
    1
    Buy
    3
    Hold
    0
    Sell
    0
    Strong Sell
    0

    SINT Bull Case vs Bear Case

    Bull case

    • SINT grew quarterly revenue 199.3% year over year.

    Bear case

    • SINT beat EPS estimates in 25.0% of its last 8 reported quarters.

    SINT Earnings: Beat Rate and Next Report

    Beat rate
    2 of 8 quarters (25.0%)
    Average surprise
    -87.7%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.31
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    2 up, 0 down

    Frequently Asked Questions About SINT

    Does SINT pay dividends?

    SINTX Technologies Inc (SINT) does not currently pay a regular dividend.

    What is SINT's market cap?

    SINTX Technologies Inc (SINT) has a market capitalization of $13.76M with a current stock price of $2.07.

    Related stocks

    Sector: Healthcare

    All stocks starting with S

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In